Google DeepMind CEO Demis Hassabis Announces AI-Driven Cancer Drug Trials to Begin in Early 2026, Robotics Breakthroughs Expected

Demis Hassabis says Isomorphic Labs has 17 active projects, with a first anticancer trial slated for early 2026. He also predicts major robotics advances in 18 months. AI’s drug discovery pipeline is heating up—and the physical world is next.

📖 Read the Full Brief